About this role
Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.
As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
Summary of Position: The Sr MSL role will represent the real time voice of KOL/HCP input related product development opportunities and scientific exchange on pipeline and commercial products; conduct clinical presentations to payer organizations. The ideal candidate will be a strong leader with a proven ability to leverage their high scientific acumen to engaged and educate on scientifically complex concepts and products. The preferred candidate will also have a proven strategic and innovative style combined with a flexible, hands-on nature that works with a high sense of urgency.